1. Home
  2. CLSD vs WKEY Comparison

CLSD vs WKEY Comparison

Compare CLSD & WKEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • WKEY
  • Stock Information
  • Founded
  • CLSD 2011
  • WKEY 1999
  • Country
  • CLSD United States
  • WKEY Switzerland
  • Employees
  • CLSD N/A
  • WKEY N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • WKEY EDP Services
  • Sector
  • CLSD Health Care
  • WKEY Technology
  • Exchange
  • CLSD Nasdaq
  • WKEY Nasdaq
  • Market Cap
  • CLSD 68.4M
  • WKEY 74.5M
  • IPO Year
  • CLSD 2016
  • WKEY N/A
  • Fundamental
  • Price
  • CLSD $0.35
  • WKEY $5.30
  • Analyst Decision
  • CLSD Hold
  • WKEY Strong Buy
  • Analyst Count
  • CLSD 4
  • WKEY 1
  • Target Price
  • CLSD $4.33
  • WKEY $4.00
  • AVG Volume (30 Days)
  • CLSD 582.0K
  • WKEY 53.1K
  • Earning Date
  • CLSD 08-08-2025
  • WKEY 09-29-2025
  • Dividend Yield
  • CLSD N/A
  • WKEY N/A
  • EPS Growth
  • CLSD N/A
  • WKEY N/A
  • EPS
  • CLSD N/A
  • WKEY N/A
  • Revenue
  • CLSD $4,166,000.00
  • WKEY $11,875,000.00
  • Revenue This Year
  • CLSD $98.20
  • WKEY $32.29
  • Revenue Next Year
  • CLSD $213.77
  • WKEY $89.83
  • P/E Ratio
  • CLSD N/A
  • WKEY N/A
  • Revenue Growth
  • CLSD N/A
  • WKEY N/A
  • 52 Week Low
  • CLSD $0.29
  • WKEY $1.61
  • 52 Week High
  • CLSD $1.65
  • WKEY $14.00
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 33.25
  • WKEY 44.54
  • Support Level
  • CLSD $0.39
  • WKEY $5.07
  • Resistance Level
  • CLSD $0.36
  • WKEY $5.80
  • Average True Range (ATR)
  • CLSD 0.03
  • WKEY 0.32
  • MACD
  • CLSD 0.00
  • WKEY 0.02
  • Stochastic Oscillator
  • CLSD 14.77
  • WKEY 49.60

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About WKEY WISeKey International Holding Ltd

WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.

Share on Social Networks: